4D MOLECULAR THERAPEUTICS IN's ticker is FDMT and the CUSIP is 35104E100. A total of 112 filers reported holding 4D MOLECULAR THERAPEUTICS IN in Q3 2023. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| US BANCORP \DE\ | 264 | $3,361 | 0.00% |
| SIMPLEX TRADING, LLC | 266 | $3 | 0.00% |
| FRANKLIN RESOURCES INC | 14,362 | $182,828 | 0.00% |
| Parallel Advisors, LLC | 0 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 137,530 | $1,750,758 | 0.00% |
| Russell Investments Group, Ltd. | 16 | $204 | 0.00% |
| WELLS FARGO & COMPANY/MN | 32,095 | $408,569 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 14,945 | $190,250 | 0.00% |
| LAZARD ASSET MANAGEMENT LLC | 2,293 | $28 | 0.00% |
| GROUP ONE TRADING, L.P. | 425 | $5,410 | 0.00% |
| Legal & General Group Plc | 24,411 | $310,752 | 0.00% |
| Allspring Global Investments Holdings, LLC | 523 | $6,657 | 0.00% |
| ALLIANCEBERNSTEIN L.P. | 83,270 | $1,060,027 | 0.00% |
| Newbridge Financial Services Group, Inc. | 30 | $382 | 0.00% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 21,490 | $274 | 0.00% |
External links
This page lists 4D MOLECULAR THERAPEUTICS IN's shareholders in Q3 2023. To view 4D MOLECULAR THERAPEUTICS IN's shareholder history, click here.